AspH is upregulated in several cancer-types and is reported to be translocated from the endoplasmic reticulum (ER) membrane to the cell surface, a process which is reported to correlate with enhanced tumour invasiveness and poor prognosis3–6. This evidence concerns the gene ASPH and cancer.